AltrixBio
altrixbio.com
Actively hiring
Lifestyle
Weight Management
Health Care
Follow
Overview
Salaries
Products
People
Growth
Offices
Financials
Funding and backers
Total raised
$14.4M
3 rounds on record
Latest round
$1.2M
Venture round · Apr 2025 · 16 mo ago
Team
1
US Form 5500 (plan participants) · Dec 2024
Backers
1
Walnut Venture Associates
The money's age
Due for its next round
16 months since the last round · not hiring
Momentum
0/100
no fresh signals
Funding rounds
| Round | Date | Amount | Investors | Source |
|---|---|---|---|---|
| Venture round | Apr 2025 | $1.2M | — | SEC Form D |
| Convertible Note | Mar 2019 | $6.6M | — | SEC Form D |
| Convertible Note | Mar 2019 | $6.6M | — | SEC Form D |
Registers and programsofficial lists and records that name the company
| Legal entity | AltrixBio, Inc. | sec |
Founders and leadersfrom filings, registers and the company's site
Nancy BriefsExecutive Officer, DirectorSEC Form D
Backed byfrom the funds' portfolios and accelerator catalogs
Walnut Venture Associates Similar startupsby what they do, their industry and backers
Cincinnati-based surgical procedure company focused on innovative development, commercialization of medical devices for treatment of…
Physician-led 12-week programs for type 2 diabetes, weight loss, and chronic conditions. Free with your provincial health card in BC…
Searching for primary care or obesity medicine, we are here to serve you with warmth and expertise. No shame. No blame. Just care. Become a…
Levels is a New York health technology company founded in 2019 that interprets continuous glucose data for metabolic health. Its app…
Award-winning digital therapeutic programs for diabetes care and weight loss trusted by doctors. 15K+ people have prevented, managed and…
De la prescription médicale à la stabilisation vous êtes accompagné à chaque étape de votre perte de poids.
Overview
AJN 003 (LuCI™) by AltrixBio delivers the life-changing metabolic effects of bariatric surgery in a once-daily pill. Learn how our breakthrough oral therapy is redefining treatment for type 2 diabetes and obesity without surgery, injections, or systemic absorption.
People
Nancy Briefs
Executive Officer, Director
John Brooks
Director
Jeffrey Karp
Director
Ali Tavakkoli
Director
Names and roles come from public filings, company registers and the company's own site. Is this you? Correct or remove
Offices
Where the company hires and what each office is for
Cities
2
Hiring now
0
Countries
1
Loading the map
Headquarters
Builds here
Office with open vacancies
No open vacancies right now Tap a pin for the office
Lowell
United States
HQ